Expression of Bax and Bcl-2 proteins, regulators of programmed cell death, in human brain tumors

Neurological Research

Volumn 19, Issue 6, 1997, Pages 623-628

  Hara, Akira ^a   Hirose, Yoshinobu ^a   Yoshimi, Naoki ^a   Tanaka, Takuji ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bax; Bcl 2; Brain tumors; Human; Programmed cell death

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BENIGN TUMOR; BRAIN CANCER; BRAIN TUMOR; CELL DEATH; CHILD; CHOROID PLEXUS PAPILLOMA; CLINICAL ARTICLE; CRANIOPHARYNGIOMA; EPENDYMOMA; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; MENINGIOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0031467457     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740871     Document Type: Article

References (14)

1. McConkey DJ, Orrenius S, Jondal M. Cellular signalling in programmed cell death (apoptosis). Immunol Today 1990; 11: 120-121
2. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77
3. Krammer PH, Behrmann I, Daniel PT, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994; 6: 279-289
4. Gillardon F, Wickert H, Zimmermann M. Differential expression of bcl-2 and bax mRNA in axotomized dorsal root ganglia of young and adult rats. Eur J Neurosci 1994; 6: 1641-1644
5. Oltvai ZN, Millman CL, Korsmeyer SL. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax that accelerates programmed cell death. Cell 1993; 74: 609-619
6. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965
7. Vaux DL, Cony S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 1988; 335: 440-442
8. Guillouf C, Grana X, Selvakumaran M, De Luca A, Giordano A, Hoffman B, Liebermann DA. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: Blocking p53-induced apoptosis unmasks G1 arrest. Blood 1995; 85: 2691-2698
9. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321-323
10. Hellemans P, Dam PA, Weyler J, Oosterom AT, Buytaert P, Marck E. Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 1995; 72: 354-360
11. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994; 145: 1191-1198
12. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995; 75: 2209-2213
13. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993; 143: 1543-1550
14. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J. Bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994; 88: 520-526